178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
Can a DNA construction kit replace expensive antibody medication?

Can a DNA construction kit replace expensive antibody medication?

by KU LeuvenCredit: CC0 Public DomainResearchers at KU Leuven in Belgium have developed a technique to make sheep produce new antibodies simply by injecting the DNA building blocks. This approach

Can a DNA construction kit replace expensive antibody medication?

by KU LeuvenCredit: CC0 Public DomainResearchers at KU Leuven in Belgium have developed a technique to make sheep produce new antibodies simply by injecting the DNA building blocks. This approach
Examining inflammatory bowel disease after a stem cell transplant

Examining inflammatory bowel disease after a stem cell transplant

byUniversity of BaselColon sections of the index patient in active IBDvs. clinical remission (under infliximab therapy) were stained by immune histology for CD5 (a pan T cell marker) and f

Examining inflammatory bowel disease after a stem cell transplant

byUniversity of BaselColon sections of the index patient in active IBDvs. clinical remission (under infliximab therapy) were stained by immune histology for CD5 (a pan T cell marker) and f
Immune receptor provides protective immunity against Group A Streptococcus

Immune receptor provides protective immunity against Group A Streptococcus

by Osaka UniversityFig. 1: The mechanism by which group A Streptococcus (GAS) evades the immune system. The immune receptor Mincle recognizes MGDG, an immunoactivating lipid present on GAS, and t

Immune receptor provides protective immunity against Group A Streptococcus

by Osaka UniversityFig. 1: The mechanism by which group A Streptococcus (GAS) evades the immune system. The immune receptor Mincle recognizes MGDG, an immunoactivating lipid present on GAS, and t
COVID infection may boost antibodies for up to 20 months

COVID infection may boost antibodies for up to 20 months

If you've already had COVID-19, your natural antibodies may last as long as 20 months, a new study suggests.While this is reassuring, experts are quick to caution that the new findings don't n

COVID infection may boost antibodies for up to 20 months

If you've already had COVID-19, your natural antibodies may last as long as 20 months, a new study suggests.While this is reassuring, experts are quick to caution that the new findings don't n
PFAS shown to reduce the activity of immune cells

PFAS shown to reduce the activity of immune cells

by Helmholtz Association of German Research CentresGraphical abstract. Credit:Chemosphere(2023). DOI: 10.1016/j.chemosphere.2023.139204PFAS are used in many everyday products. This is

PFAS shown to reduce the activity of immune cells

by Helmholtz Association of German Research CentresGraphical abstract. Credit:Chemosphere(2023). DOI: 10.1016/j.chemosphere.2023.139204PFAS are used in many everyday products. This is
COVID-19: Biomarkers linked to severe forms of the disease

COVID-19: Biomarkers linked to severe forms of the disease

by University of MontrealColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captu

COVID-19: Biomarkers linked to severe forms of the disease

by University of MontrealColorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captu
One step closer to tailored treatment of severe rheumatic diseases

One step closer to tailored treatment of severe rheumatic diseases

by Aarhus UniversityThe study leads us to hope that the immunological cells and inflammatory signalling molecules in the joint of each individual patient will be able to predict the most effectiv

One step closer to tailored treatment of severe rheumatic diseases

by Aarhus UniversityThe study leads us to hope that the immunological cells and inflammatory signalling molecules in the joint of each individual patient will be able to predict the most effectiv
High false negative rate with PFTs in scleroderma lung disease

High false negative rate with PFTs in scleroderma lung disease

(HealthDay)—Use of pulmonary function tests (PFTs) is associated with high false negative rates for detection of scleroderma-associated interstitial lung disease (SSc-ILD), according to a study publis

High false negative rate with PFTs in scleroderma lung disease

(HealthDay)—Use of pulmonary function tests (PFTs) is associated with high false negative rates for detection of scleroderma-associated interstitial lung disease (SSc-ILD), according to a study publis
Arthritis, other chronic disease takes toll on work force

Arthritis, other chronic disease takes toll on work force

(HealthDay)—Among adults with one or more chronic conditions, those with arthritis appear much more likely than those without arthritis to have work disability, according to research published in the

Arthritis, other chronic disease takes toll on work force

(HealthDay)—Among adults with one or more chronic conditions, those with arthritis appear much more likely than those without arthritis to have work disability, according to research published in the
Inflammation can lead to circadian sleep disorders

Inflammation can lead to circadian sleep disorders

by Northwestern UniversityCredit: CC0 Public DomainInflammation, which is the root cause of autoimmune disorders including arthritis, Type 1 diabetes, irritable bowel syndrome and Crohn's dis

Inflammation can lead to circadian sleep disorders

by Northwestern UniversityCredit: CC0 Public DomainInflammation, which is the root cause of autoimmune disorders including arthritis, Type 1 diabetes, irritable bowel syndrome and Crohn's dis
Yearly treatment could slow osteoarthritis

Yearly treatment could slow osteoarthritis

by Monash UniversityCredit: ThinkStock(Medical Xpress)—Researchers are trialling a once-a-year treatment to slow osteoarthritis.Led by Monash University Professor Flavia Cicuttini, the rese

Yearly treatment could slow osteoarthritis

by Monash UniversityCredit: ThinkStock(Medical Xpress)—Researchers are trialling a once-a-year treatment to slow osteoarthritis.Led by Monash University Professor Flavia Cicuttini, the rese
Lab-created molecule achieves positive results in the treatment of arthritis

Lab-created molecule achieves positive results in the treatment of arthritis

by FAPESPArthritic mouse paw treated with TPPU (left) and untreated paw of another arthritic mouse. The substance decreased the area affected, reduced local swelling, and assuaged the pain associ

Lab-created molecule achieves positive results in the treatment of arthritis

by FAPESPArthritic mouse paw treated with TPPU (left) and untreated paw of another arthritic mouse. The substance decreased the area affected, reduced local swelling, and assuaged the pain associ